Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity
- 21 April 2006
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 49 (6) , 1360-1370
Abstract
Obese people exhibit reduced circulating peptide YY (PYY) levels, but it is unclear whether this is a consequence or cause of obesity. We therefore investigated the effect of Pyy ablation on energy homeostasis.Keywords
This publication has 40 references indexed in Scilit:
- Energy Homeostasis and Gastrointestinal Endocrine Differentiation Do Not Require the Anorectic Hormone Peptide YYMolecular and Cellular Biology, 2005
- Peptide YY Directly Inhibits Ghrelin-Activated Neurons of the Arcuate Nucleus and Reverses Fasting-Induced c-Fos ExpressionNeuroendocrinology, 2004
- Physiology: Does gut hormone PYY3–36 decrease food intake in rodents?Nature, 2004
- Effects of PYY[3–36] in rodent models of diabetes and obesityInternational Journal of Obesity, 2004
- Neuropeptide Y promotes β-cell replication via extracellular signal-regulated kinase activationBiochemical and Biophysical Research Communications, 2004
- Inhibition of Food Intake in Obese Subjects by Peptide YY3–36New England Journal of Medicine, 2003
- Effects of dietary cholestyramine on the utilisation of diets containing medium or long chain triacylglycerols by chicksBritish Poultry Science, 1997
- Y-receptor subtypes—how many more?Trends in Neurosciences, 1997
- Metabolic Actions of Growth Hormone in Man.Endocrine Journal, 1996
- Peptide YYPancreas, 1989